Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.83684 | 35 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.77691 | 34 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.78296 | 34 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.70208 | 33 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.70641 | 33 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.88419 | 35 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.91079 | 37 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.85357 | 38 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.73106 | 33 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.75939 | 34 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.76981 | 34 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.73217 | 34 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.7737 | 34 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.78263 | 35 |